Important Update: TGA Decision on Andrographis paniculata

The Therapeutic Goods Administration (TGA) has announced the removal of Andrographis paniculata from the list of permissible ingredients for new listed medicines in Australia, effective 17 September 2026. This decision follows ongoing safety reviews and reports of serious allergic reactions, including anaphylaxis, associated with products containing Andrographis.

• Read More